| Literature DB >> 21683787 |
Russell Riehl1, Evan Kyzar, Alexander Allain, Jeremy Green, Molly Hook, Louis Monnig, Kate Rhymes, Andrew Roth, Mimi Pham, Roshan Razavi, John Dileo, Siddharth Gaikwad, Peter Hart, Allan V Kalueff.
Abstract
Ketamine is a non-competitive glutamatergic antagonist used to induce sedation and analgesia. In sub-anesthetic doses, it induces hyperlocomotion, impairs memory and evokes stereotypic circling in rodents. Zebrafish (Danio rerio) emerged as a promising new animal model to screen the effects of psychotropic compounds. Here, we investigated the effects of sub-anesthetic doses of ketamine on anxiety, locomotion, habituation and social behavior of adult zebrafish. Acute 20-min exposure to 20 and 40 mg/L (but not 2 mg/L) of ketamine reduced anxiety, impaired intra-session habituation, evoked circular swimming and disrupted zebrafish shoaling. Additionally, ketamine reduced whole-body cortisol levels and elevated brain c-fos expression in zebrafish. Our findings demonstrate the sensitivity of zebrafish to behavioral and physiological effects of sub-anesthetic doses of ketamine, further supporting the utility of this species as a model for neuropharmacological research, including testing ketamine and related drugs.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21683787 DOI: 10.1016/j.ntt.2011.05.011
Source DB: PubMed Journal: Neurotoxicol Teratol ISSN: 0892-0362 Impact factor: 3.763